| Market Cap | ₹13,455Cr |
| ROE | 12.88% |
| P/E Ratio(TTM) | 26.24 |
| EPS(TTM) | 21.13 |
| P/B Ratio | 3.38 |
| Dividend Yield | 0.27% |
| Industry P/E | 32.95 |
| Book Value | 164.12 |
| Debt to Equity | 0.45 |
| Face Value | 1 |
| Parent Organisation | Granules India Limited |
| Managing Director | Dr. K.V.S. Ram Rao |
| Founded | 1991 |
| NSE Symbol | GRANULES |
| FUND NAME | AUM(%) |
|---|---|
| Tata Large Cap Direct Plan Growth | 1.05% |
| Tata Mid Cap Direct Plan Growth | 1.03% |
| Axis Value Fund Direct Growth | 1.00% |
| Edelweiss Balanced Advantage Fund Direct Growth | 0.94% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.50 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.62 | ||
| Wockhardt | NA (0.00%) | -424.60 | ||
| Cohance Lifesciences | NA (0.00%) | 64.50 |